Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122850784 | 12285078 | 4 | F | 201601 | 20160727 | 20160420 | 20160801 | EXP | FR-009507513-1604FRA010976 | MERCK | 56.51 | YR | F | Y | 0.00000 | 20160801 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122850784 | 12285078 | 1 | PS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 1 DF, PER CYCLE | Y | 62756 | 1 | DF | INTRAVENOUS INJECTION | ||||||
| 122850784 | 12285078 | 2 | SS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 1 DF, PER CYCLE | Y | 62756 | 1 | DF | INTRAVENOUS INJECTION | ||||||
| 122850784 | 12285078 | 3 | SS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 1 DF, PER CYCLE | Y | 62756 | 1 | DF | INTRAVENOUS INJECTION | ||||||
| 122850784 | 12285078 | 4 | SS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 1 DF, PER CYCLE | Y | 62756 | 1 | DF | INTRAVENOUS INJECTION | ||||||
| 122850784 | 12285078 | 5 | SS | CANCIDAS | CASPOFUNGIN ACETATE | 1 | UNK, CYCLICAL | Y | 0 | INJECTION | |||||||||
| 122850784 | 12285078 | 6 | SS | CANCIDAS | CASPOFUNGIN ACETATE | 1 | UNK, CYCLICAL | Y | 0 | INJECTION | |||||||||
| 122850784 | 12285078 | 7 | SS | ZYVOXID | LINEZOLID | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 122850784 | 12285078 | 8 | SS | ZYVOXID | LINEZOLID | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 122850784 | 12285078 | 9 | SS | ZYVOXID | LINEZOLID | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122850784 | 12285078 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122850784 | 12285078 | Eosinophilia | |
| 122850784 | 12285078 | Monocytosis | |
| 122850784 | 12285078 | Toxic skin eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122850784 | 12285078 | 1 | 20151225 | 20160103 | 0 | |
| 122850784 | 12285078 | 2 | 20160113 | 20160121 | 0 | |
| 122850784 | 12285078 | 3 | 20160108 | 20160205 | 0 | |
| 122850784 | 12285078 | 4 | 20160209 | 20160217 | 0 | |
| 122850784 | 12285078 | 5 | 20151230 | 20160106 | 0 | |
| 122850784 | 12285078 | 6 | 20160120 | 20160219 | 0 | |
| 122850784 | 12285078 | 7 | 20160120 | 20160126 | 0 | |
| 122850784 | 12285078 | 8 | 20160129 | 20160208 | 0 | |
| 122850784 | 12285078 | 9 | 20160215 | 20160218 | 0 |